Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Current Problems in Diagnostic Radiology|March 22, 2021
What People Tweet about Imaging CostsKartik Meda, William Wagstaff, Gelareh Sadigh, et al.
Nuclear Medicine Communications|April 2, 2021
Determination of tumour dose response threshold and implication on survival in patients with HCC treated with Y90 radiation segmentectomy: a simple semi-quantitative analysisBernard Cheng, Ila Sethi, Alex Villalobos, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 1, 2021
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CTAlexander Villalobos, Bernard Cheng, William Wagstaff, et al.
Cardiovascular and Interventional Radiology|April 23, 2021
Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 RadioembolizationBernard Cheng, Alex Villalobos, Ila Sethi, et al.
Cardiovascular and Interventional Radiology|July 27, 2021
Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular CarcinomaMohammad Elsayed, William Wagstaff, Keywan Behbahani, et al.
Radiology. Artificial Intelligence|April 8, 2022
Overview of Noninterpretive Artificial Intelligence Models for Safety, Quality, Workflow, and Education Applications in Radiology PracticeYasasvi Tadavarthi, Valeria Makeeva, William Wagstaff, et al.
Canadian Journal of Gastroenterology & Hepatology|August 2, 2021
Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular CarcinomaAlexander Villalobos, William Wagstaff, Mian Guo, et al.
Cardiovascular and Interventional Radiology|November 24, 2020
Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched StudyLinzi Arndt, Alexander Villalobos, William Wagstaff, et al.
Aging|July 7, 2021
Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathwaysLinjuan Huang, Ling Zhao, Jing Zhang, et al.
Genes & Diseases|July 3, 2023
Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancerLinjuan Huang, Jing Zhang, Youling Deng, et al.
Pageof 5